The Centers for Medicare and Medicaid Services (CMS) identified 15 drugs it has selected for price negotiations with drug ...

Former Trump administration health official Joe Grogan applauds Biden proposal that Medicare and Medicaid cover GLP-1 ...

On Friday, the U.S. Department of Health and Human Services (HHS) unveiled the selection of 15 additional drugs covered under ...

Niall Stanage chats with The Hill’s Mychael Schnell as President Elect Trump’s nominees face tough questions in the Senate. Mychael has the latest on the confirmations plus the details of Biden’s ...

U.S. Health and Human Services Secretary Xavier Becerra says “this is a big deal.” Drug companies oppose the program.

A high-dose form of Novo’s obesity drug led to 20% weight loss over 72 weeks. Meanwhile, Atara got a complete response letter and Boehringer reported a Phase 3 failure.

Popular weight loss and diabetes drugs like Ozempic and Wegovy have been added to Medicare's list of medications that will be ...

List of drugs account for $41 billion in annual Medicare spending, the Biden administration said.

GLP-1 drugs do a lot more than just help you lose weight. They can help your heart, brain, and more, but beware what they ...

The Biden administration announced Friday that popular weight loss drugs Ozempic and Wegovy will be included on Medicare's list of medications subject to direct price negotiations with manufacturers.

Biden administration selects 15 new medications up for price negotiations including weight loss drugs Ozempic and Wegovy.

The two blockbusters Novo Nordisk medicines are among 15 additional drugs whose prices Medicare will be allowed to negotiate with drugmakers.